[HTML][HTML] Metastatic donor-derived malignancies following simultaneous pancreas-kidney transplant: three case reports and management strategies

D Amara, SA Wisel, HJ Braun, EA Collisson… - Transplantation …, 2021 - journals.lww.com
Background. Stopping immunosuppression in a transplant patient with donor-derived
malignancy offers the theoretical benefit that reconstitution of the patient's immune system …

Cancer du sein et greffe d'organes: revue systématique et méta-analyse

M Lapointe, F Kerbaul, F Meckert, N Cognard… - … Obstétrique Fertilité & …, 2023 - Elsevier
Résumé Objectifs Notre objectif principal a été d'établir un état des lieux des cas de cancers
épithéliaux de toutes origines transmis par les donneurs en comparaison avec les cancers …

Donor-Transmitted Melanoma: Is It Still Bothering Us?

L Abdullayeva - Current Treatment Options in Oncology, 2020 - Springer
Opinion statement Global organ scarcity remains a severe obstacle because of the rapid
growth in the number of patients on the transplant waiting list. Transplant centres strive to …

Cancer and Kidney Failure; Screening, Mortality, and Transmission

BM Rosales - 2021 - ses.library.usyd.edu.au
Cancer impacts people with kidney failure in multiple ways, however, we still do not fully
understand the epidemiology of cancer mortality, feasibility of cancer screening and …

[PDF][PDF] Metastatic Donor-derived Malignancies Following Simultaneous Pancreas-kidney

D Amara, SA Wisel, HJ Braun - Transplantation, 2021 - scholar.archive.org
Background. Stopping immunosuppression in a transplant patient with donor-derived
malignancy offers the theoretical benefit that reconstitution of the patient's immune system …